Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Crit Care
Egile Nagusiak: Menzella, Francesco, Fontana, Matteo, Salvarani, Carlo, Massari, Marco, Ruggiero, Patrizia, Scelfo, Chiara, Barbieri, Chiara, Castagnetti, Claudia, Catellani, Chiara, Gibellini, Giorgia, Falco, Francesco, Ghidoni, Giulia, Livrieri, Francesco, Montanari, Gloria, Casalini, Eleonora, Piro, Roberto, Mancuso, Pamela, Ghidorsi, Luca, Facciolongo, Nicola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523258/
https://ncbi.nlm.nih.gov/pubmed/32993751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03306-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak